Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rebbeck TR et al. - Results confirm that FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors. Further report that these genes confer their effects in HER2– tumors, interact with one another to confer breast cancer susceptibility in AA women and interact with hormone exposures in AA and EA women.


Today in Breast...keeping you current

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 11/17/09

Activity of fulvestrant in HER2-overexpressing advanced breast cancer
Annals of Oncology, 11/06/09

Vitamin D association with estradiol and progesterone in young women
Cancer Causes and Control, 11/23/09

Today in Carcinogenesis...keeping you current

Antitumorigenic effects of cannabinoids beyond apoptosis
Journal of Pharmacology and Experimental Therapeutics, 11/06/09

The emerging role of the distal Fallopian tube and p53 in pelvic serous carcinogenesis
The Journal of Pathology, 11/05/09

Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis
Oncogene, 11/05/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address